Concepedia

Gulidanna Shayan

GS

14

Publications

1.6K

Citations

11

H-Index

2015

Active since

Affiliations

UPMC Hillman Cancer Center(Current)

University of Pittsburgh

Tsinghua University

Chinese Academy of Medical Sciences & Peking Union Medical College

Dana-Farber Cancer Institute

Gulidanna Shayan is an author at UPMC Hillman Cancer Center specializing in medicine, immune regulation, and tumor immunity.

ORCID

Top concepts

Publications per year

2015–2023

14

Publications

14

Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity

Abigail E. Overacre-Delgoffe, Maria Chikina, Rebekah Dadey et al. · Cell · 2017 · 592 citations · Full text

, , +6

Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer

Gulidanna Shayan, Raghvendra M. Srivastava, Jing Li et al. · OncoImmunology · 2016 · 294 citations · Full text

PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer

Benjamin Kansy, Fernando Concha‐Benavente, Raghvendra M. Srivastava et al. · Cancer Research · 2017 · 242 citations · Full text

Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients

Zhuqing Liu, Elizabeth L. McMichael, Gulidanna Shayan et al. · Clinical Cancer Research · 2018 · 117 citations · Full text

Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals

Gulidanna Shayan, Benjamin Kansy, Sandra P. Gibson et al. · Clinical Cancer Research · 2017 · 78 citations · Full text

Rows per page

1–5 of 14